VirnetX Holding Corp VHC
10.36
(1.87)
(15.29%)
as of 25 Sep
- Market cap
- $51.6M
- P/E
- 0.0×
Follow VHC
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
P/E ratio |
+8 more quarters Free account |
0.00 | 0.00 | — | — |
P/S ratio |
611.83 | 375.73 | — | — | |
P/FCF ratio |
0.00 | 0.00 | — | — | |
P/Operating CF |
(22.00) | (10.48) | — | — | |
P/B ratio |
2.26 | 2.71 | — | — | |
Price to Tangible BV |
2.26 | 2.71 | — | — | |
EV/Sales |
350.78 | 242.85 | — | — | |
EV/EBITDA |
0.00 | 0.00 | — | — | |
EV/Operating CF |
(2.47) | (2.51) | — | — | |
EV/FCF |
(2.46) | (2.51) | — | — | |
Quick Ratio |
13.62 | 10.64 | 8.37 | 6.15 | |
Current Ratio |
13.72 | 10.70 | 8.53 | 6.24 | |
Net Debt/EBITDA |
6.08 | 3.17 | 3.83 | 2.99 | |
Debt/Assets |
0.00% | 0.00% | 0.00% | 0.00% | |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.00 | |
Asset Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
0.69 | 0.88 | 0.99 | 0.73 | |
Capex/Depreciation |
(2.83) | 0.00 | 0.00 | (1.14) | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
1,970.69% | 3,637.50% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
5,274.14% | 8,614.29% | 0.00% | 0.00% | |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | |
Share Based Compensation of Revenue |
827.59% | 1,103.57% | 0.00% | 0.00% | |
Graham Net Nets |
0.30 | 0.21 | — | — | |
Graham Number |
0.00 | 0.00 | — | — | |
Earnings Yield |
(27.29%) | (30.02%) | — | — | |
Free Cash Flow Yield |
(23.28%) | (25.75%) | — | — | |
Revenue per Share |
0.02 | 0.02 | 0.00 | 0.00 | |
Operating CF per Share |
(0.82) | (1.59) | (1.14) | (0.88) | |
Capex per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Free Cash Flow per Share |
(0.82) | (1.59) | (1.14) | (0.88) | |
Cash per Share |
7.68 | 5.90 | 4.59 | 3.68 | |
Shareholders Equity per Share |
7.97 | 6.16 | 5.02 | 4.00 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
7.97 | 6.16 | 5.02 | 4.00 | |
Free Cash Flow |
(3.02) | (5.81) | (4.30) | (3.33) | |
Working Capital |
26.36 | 19.64 | 15.50 | 11.85 | |
Capital Expenditures |
(0.02) | 0.00 | — | (0.01) | |
Net Current Asset Value |
19.74 | 13.08 | 9.72 | 6.20 | |
EV/EBIT |
0.00 | 0.00 | — | — | |
Capex to Sales |
0.29 | 0.00 | — | 0.00 | |
Net Profit Margin |
(7,496.55%) | (11,744.64%) | 0.00% | 0.00% | |
Price to Operating Income |
0.00 | 0.00 | — | — | |
| Other line items | |||||
Average Receivables |
0.01 | 0.01 | — | — | |
Average Payables |
0.33 | 0.36 | 0.34 | 0.39 | |
Average Assets |
46.79 | 40.34 | 35.90 | 32.40 | |
Average Common Equity |
37.39 | 31.05 | 27.61 | 24.12 |
Columns are period end dates